Jane Street Group, LLC Adverum Biotechnologies, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021
BUY
$2.08 - $3.6 $21,216 - $36,720
10,200 Added 58.62%
27,600 $60,000
Q2 2021

Aug 16, 2021
BUY
$3.36 - $10.56 $17,136 - $53,856
5,100 Added 41.46%
17,400 $61,000
Q2 2020

Aug 17, 2020
BUY
$8.53 - $25.64 $104,918 - $315,372
12,300 New
12,300 $257,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email